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Epidemiological parameters, such as age-dependent force of infection and average age at infection (ā) were 
estimated for rubella, varicella, rotavirus A, respiratory syncytial virus, hepatitis A and parvovirus B19 infections 
for a non-immunized Brazilian community, using the same sera samples. The ā for the aforementioned diseases were 
8.45 years (yr) [95% CI: (7.23, 9.48) yr], 3.90 yr [95% CI: (3.51, 4.28) yr], 1.03 yr [95% CI: (0.96, 1.09) yr], 1.58 yr 
[95% CI: (1.39, 1.79) yr], 7.17 yr [95% CI: (6.48, 7.80) yr] and 7.43 yr [95% CI: (5.68, 9.59) yr], respectively. The dif-
ferences between average ages could be explained by factors such as differences in the effectiveness of the protection 
conferred to newborns by maternally derived antibodies, competition between virus species and age-dependent host 
susceptibility. Our seroprevalence data may illustrate a case of the above-mentioned mechanisms working together 
within the same population.
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Certain viral infections are more likely to occur 
around a given age. For example, rotavirus and respira-
tory syncytial virus (RSV) typically occur in children 
under three years of age, while rubella affects 5-9-year-
olds (Knipe & Howley 2007).
Utilizing seroprevalence data, it is possible to estimate 
epidemiological parameters and subsequently analyse the 
dynamics of an infectious disease in different populations. 
Examples of this approach include analyses of measles, 
mumps and rubella seroprevalence in different European 
countries (Edmunds et al. 2000) and in countries in Eu-
rope and Latin America (Amaku et al. 2003). A comple-
mentary approach is to analyse the dynamics of different 
infectious diseases within the same community.
Information about the average age at infection (ā) 
will help us characterize the dynamics of an infection 
in a population. A higher incidence of cases in people 
of younger or older ages may be associated with several 
factors, such as sanitary conditions, population density 
(Almeida et al. 2002), age at which children enter the 
school system (Yu et al. 2001) and other social and eco-
nomic variables. For instance, improvements in sanitation 
as well as the introduction of a vaccination programme 
may lead to changes in the ā, which demonstrates the 
importance of this parameter in the assessment of both 
the effects of an environmental control programme and 
the efficacy of a vaccination strategy.
To characterise the dynamics of different infectious 
diseases in the same population, we have estimated the 
force of infection (λ (a)) and the ā, based on data from a 
seroprevalence survey carried out in a Brazilian commu-
nity for antibodies against the following viruses: rubella, 
varicella, group A rotavirus (rotaA), human RSV, hepa-
titis A (HAV) and human parvovirus B19 (parvoB19). 
We have also estimated confidence intervals for ā using 
Monte Carlo simulations.
SUBJECTS, MATERIALS AND METHODS
Data consisted of seroprevalence surveys for IgG anti-
bodies against rubella (Azevedo Neto et al. 1994), varicella 
(Valentim et al. 2008), rotaA (Cox et al. 1998b), RSV (Cox et 
al. 1998a), HAV (unpublished data) and parvoB19 (Huatuco 
et al. 2008) carried out in the community of Caieiras, a small 
town in the state of São Paulo (SP), Brazil. The population 
of Caieiras was about 30,000 inhabitants in 1990, most of 
them inhabiting an urban area occupying 104 km2. Samples 
were collected from 476 individuals randomly selected by 
cluster sampling from November 1990-January 1991. The 
seroprevalence study was carried out in dwellings from 30 
of the 60 administrative regions to obtain a sample repre-
sentative of the population living in Caieiras, including new-
borns to adults 40 years of age. More details are published 
elsewhere (Azevedo Neto et al. 1994).
Let S+(a) be the proportion of seropositive individu-
als with age a. An estimate of the function S+(a) resulted 
from fitting the serological data to each disease (Far-
rington 1990, Amaku et al. 2003)
S+(a)=1−exp [(k2a+1)e
−k2a−1]
k1
k2
2
, (1)
where k1 and k2 are fitting parameters, estimated by either the 
Maximum Likelihood or the Least Squares technique.
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In our model, the seropositive individuals corre-
spond to those who are either infected or immune. The 
λ (a) was estimated from the seroprevalence data for the 
so-called catalytic approach (Griffiths 1974):
(1−S+(a))−1= da
dS+(a)λ0(a) . (2)
Equation (2), expressed in terms of equation (1), is
λ0(a)=k1a exp[−k2a]. (3)
From the λ (a), we can define the average age at which 
susceptibles acquire infection:
ā =
∫0
L aλ(a)s(a)da
∫0
L λ(a)s(a)da . (4)
We have taken the highest age observed in the se-
roepidemiological survey (L = 40 years) as the upper in-
tegration limit of the integrals of equation (4).
In this paper, we are assuming that the immune re-
sponse is not lost over time for the diseases studied.
Monte Carlo simulations - From the fitting procedure, 
we have estimated the variance-covariance matrix V for the 
parameters of the seroprevalence function [equation (1)]
cov(k1,k2)
cov(k1,k2)Sk
2
1
Sk
2
2
V =
, (5)
where Sk
2
i (i = 1,2) is the variance of the parameter 
ki (i = 1,2) and cov(k1, k2) the covariance between the two pa-
rameters. The fitted parameters will be indicated as kˆ1 and kˆ2.
The correlation coefficient between k1 and k2 is defined as
cov(k1,k2)
Sk1Sk2
ρ =
, (6)
and it always lies in the interval -1 ≤ ρ ≤1. If ρ =0, k1 and 
k2 are said to be uncorrelated, if ρ > 0, they are positively 
correlated and, if ρ < 0, negatively correlated.
As we have an estimate of the variance-covariance 
matrix V, we can randomly generate pairs of values (k1, 
k2) and calculate the ā.
The Monte Carlo algorithm we have adopted is based 
on the generation of random numbers for k1 and k2 and on 
the substitution of these values in equation (4) for the ā. 
We have supposed that k1 and k2 are normally distributed 
with the means kˆ1 and kˆ2 and the standard deviations Sk1 
and Sk2, respectively. Considering that the parameters 
have a covariance cov(k1, k2), the algorithm for the gen-
eration of pairs of values (k1, k2) is the following:
k1 = kˆ1+Sk1.g1()
k2 = kˆ2+Sk2.[ρ.g1()+√1−ρ
2.g2()],
where g1() and g2() are two different normal random 
generators with mean zero and variance 1. The compu-
tational routines we have used to generate random num-
bers are those described by Press et al. (1992).
RESULTS
Fig. 1 shows the fitted seroprevalence curves (Fig. 
1A) for the six infectious diseases considered and the 
respective forces of infections (Fig. 1B).
The estimates for the fitting parameters are shown 
in Table. The ā and the 95% confidence intervals esti-
mated using the Monte Carlo method for rubella, vari-
cella, rotavirus A, human RSV, HAV and parvoB19 were 
8.45 years (yr) [95% CI: (7.23, 9.48) yr], 3.90 yr [95% CI: 
(3.51, 4.28) yr], 1.03 yr [95% CI: (0.96, 1.09) yr], 1.58 yr 
[95% CI: (1.39, 1.79) yr], 7.17 yr [95% CI: (6.48, 7.80) yr] 
and 7.43 yr [95% CI: (5.68, 9.59) yr], respectively.
The highest values for the λ (a) were observed for 
rotavirus A and RSV, followed by varicella, all of which 
had an ā of less than five years. The λ (a) curve for ro-
tavirus A showed a sharp peak around one year of age, 
followed by a steep decrease and vanished after five 
years of age. The sharp peak for RSV occurred around 
two years and was followed by a decrease slower than 
that observed for rotavirus A, vanishing only after the 
age of 10 years.
The λ (a) curve for parvo B19 showed the smallest 
intensity among the infections studied.
The λ (a) curves for rubella and HAV indicated inter-
mediate intensity, being higher than that of parvo B19, 
but not reaching the intensity of the RSV and rotavirus A 
curves. The average ages observed for rubella and HAV 
were 8.45 yr and 7.17 yr, respectively.
By visual inspection, taking into account the con-
fidence intervals, differences between ā values for the 
infections studied are noticeable, with the exception of 
parvo B19 when compared to HAV and rubella (Fig. 2).
Fig. 1: A: seroprevalence data and corresponding fitted curves for 
rubella, varicella, rotavirus A infection (rota A), human respiratory 
syncytial virus (RSV), hepatitis A (HAV) and parvovirus B19 (par-
voB19) infections in the community of Caieiras (Brazil); B: force of 
infection (λ (a)) for the diseases studied.
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DISCUSSION
We analyzed seroepidemiological data for six viral 
infectious diseases in the same population. Our results 
for rotavirus A are in agreement with the prevalence 
observed by Candeias et al. (1989) in the city of São 
Paulo from data obtained in outpatient departments of 
As for parvoB19, serological data published for Rio 
de Janeiro (Nascimento et al. 1990) showed a higher 
prevalence in young adults (80%) compared with the 
data presented here for Caieiras.
The rubella seroprevalence described here for Caiei-
ras is similar to data published by Souza et al. (1994) 
for the city of São Paulo from a survey carried out on 
sera collected in 1987, which suggests that the Caieiras 
population is representative of the São Paulo metropoli-
tan region population.
Based on seroprevalence data, we estimated the age-
dependent λ (a) and the average age of first infection. 
These epidemiological parameters were used in previous 
publications to verify the effect of different vaccination 
strategies (Amaku et al. 2003).
The average age at first infection is an important 
reference for determining the optimum age for vaccine 
introduction. It was demonstrated that immunization 
for rubella is not effective if proposed for ages around 
or above the ā (Amaku et al. 2003). Although this is a 
relative simple parameter, as shown by our results, it can 
support health authorities’ decisions around establishing 
a vaccination schedule.
The application of the parameters estimated in this 
paper proved to be useful when the immunization cam-
paign against rubella was designed for SP in 1992 (Mas-
sad et al. 1994, 1995). This campaign was successful at 
reducing the incidence of rubella.
The differences observed among the epidemio-
logical parameters estimated for these six infectious 
diseases may not be solely due to the contact pattern 
among individuals because the individuals sampled are 
the same. Therefore, other factors should be considered 
as influential to the epidemiology of each disease by 
mathematical modelling.
If we consider that all viruses are circulating in the 
population, why don’t we observe constant proportions 
of population infected across all age groups?
Depending on the infection, factors such as protection 
by maternal derived antibodies, transmission route, age-
dependent host susceptibility and competition among dif-
ferent virus species may also help to explain the observed 
age-dependent pattern of disease transmission.
The decline of maternal derived antibodies from 
birth onwards may interfere with the acquisition of an 
TABLE
Fitting parameters (kˆ1 and kˆ2), standard deviations Sk1 and Sk2 and covariance cov(k1, k2) estimates for the six infectious  
diseases studied
Infection kˆ1 (yr
-2) kˆ2 (yr
-1) Sk1 (yr
-2) Sk2 (yr
-1) cov(k1, k2) (yr
-3)
Rubella 0.0456 0.108 0.0046 0.016 4.6  10-5
Varicella 0.240 0.279 0.021 0.021 3.3  10-4
Rotavirus A 3.49 1.244 0.24 0.073 1.5  10-2
Respiratory syncytial virus 1.277 0.510 0.099 0.049 3.7  10-3
Hepatitis A 0.0702 0.161 0.0064 0.015 6.8  10-5
Parvovírus B19 0.045 0.226 0.013 0.049 5.7  10-4
Fig. 2: average age of infection and 95% confidence intervals for 
rubella, varicella, rotavirus A infection (rota A), human respiratory 
syncytial virus (RSV), hepatitis A (HAV) and parvovirus B19 (par-
voB19) infections in the community of Caieiras (Brazil).
hospitals, showing this disease occurs early during in-
fancy. The same is true for RSV, as shown by Vieira 
et al. (2007).
In the case of varicella, two different samples from 
Caieiras (Yu et al. 2001, Valentim et al. 2008) showed 
similar seroprofile patterns. However, the seropreva-
lence for Caieiras is different than that of city of São 
Paulo (Yu et al. 2001) due to differences in the children’s 
social behaviour.
The HAV seroprevalence found in our analysis is 
very similar to the profile observed in the Rio de Janei-
ro metropolitan area (Almeida et al. 2002) and is typical 
of urban areas.
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infection in the first year of life, altering the average age 
at first infection. RSV, for example, requires a high titer 
of maternal derived antibodies to be neutralized, making 
infants susceptible after two months of age (Collins & 
Crowe 2007). This fact may explain the rapid spread of 
RSV infection in the first two years of life. It may also 
be the explanation for other diseases that spread among 
infants, such as rotavirus A infection.
According to our results, the route of transmission 
did not seem to make a difference in terms of when an 
infection would occur. For instance, rotavirus A and 
HAV are both mainly transmitted by a faecal-oral route, 
but the former has an average age of first infection of one 
year and the latter seven years.
Infectivity is another characteristic that varies among 
pathogens and it may be important in determining the 
success of rotavirus and RSV acquisition so early in an 
infant’s life as compared to other illnesses such as ru-
bella or parvoB19, for example.
Regarding competition among viruses, it should 
be considered that nonspecific immune responses pro-
duced by one viral infection may inhibit a concomitant 
infection by another virus. Although simultaneous virus 
infection in the same host was demonstrated for RSV, 
adenovirus, metapneumovirus, rhinovirus, enterovirus, 
influenza and parainfluenza in different combinations 
(Calvo et al. 2008), concurrent infection is less likely to 
occur, making competition a good hypothesis to explain 
why some diseases like rubella and parvoB19 appear 
less frequently in infants and toddlers.
We have observed that viral infections like rotavirus 
A and RSV have a lower average age of first infection 
as compared with varicella, which, in turn, is lower than 
HAV, parvoB19 and rubella. Our seroprevalence data 
may illustrate the above-mentioned mechanisms work-
ing together within the same population.
If it is true that there is an interaction among virus 
and human populations that drives the observed age-
dependent incidences, it is plausible that a change in the 
seroprevalence pattern of a disease may be instigated by 
the introduction of vaccine against another disease.
Further investigation of the seroprevalence profiles 
of different diseases within the same population should 
be carried out to elucidate whether such an interaction 
occurs after the introduction of immunization.
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